Chronic kidney disease and exposure to nephrotoxic metals

International Journal of Molecular Sciences

Volumn 18, Issue 5, 2017, Pages

  Orr, Sarah E ^a   Bridges, Christy C ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arsenic; Cadmium; Chronic kidney disease; Lead; Mercury

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); AQUAPORIN 3; ARSENIC; BREAST CANCER RESISTANCE PROTEIN; CADMIUM; CALCIUM CHANNEL; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 5; LEAD; MEMBRANE PROTEIN; MERCURY; MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 4; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3; ORGANIC ANION TRANSPORTER B; ORGANIC CATION TRANSPORTER 2; TOXIC SUBSTANCE; UNCLASSIFIED DRUG; ZIP14 TRANSPORTER; ZIP8 TRANSPORTER; HEAVY METAL;

CHRONIC KIDNEY FAILURE; ENDOCYTOSIS; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ESTIMATED GLOMERULAR FILTRATION RATE; GENE EXPRESSION; GLUCOSE TRANSPORT; HISTOLOGY; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MORBIDITY; MORTALITY; NEPHRON; NEPHROTOXICITY; NONHUMAN; PREVALENCE; PROTEIN EXPRESSION; REVIEW; STRUCTURE ACTIVITY RELATION; ANIMAL; COMPLICATION; HEAVY METAL POISONING; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; ENVIRONMENTAL EXPOSURE; HEAVY METAL POISONING; HUMANS; METALS, HEAVY; RENAL INSUFFICIENCY, CHRONIC;

EID: 85019215183     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18051039     Document Type: Review

References (364)

1. Price, R.G. Urinary enzymes, nephrotoxicity and renal disease. Toxicology 1982, 23, 99-134. [CrossRef]
2. Zalups, R.K.; Diamond, G.L. Mercuric chloride-induced nephrotoxicity in the rat following unilateral nephrectomy and compensatory renal growth. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 1987, 53, 336-346. [CrossRef] [PubMed]
3. Zalups, R.K.; Cox, C.; Diamond, G.L. Histological and urinalysis assessment of nephrotoxicity induced by mercuric chloride in normal and uninephrectomized rats. In Biological Monitoring of Toxic Metals; Clarkson, T.W., Friberg, L., Nordberg, G.F., Sager, P.R., Eds.; Plenum Publishing Corporation: New York, NY, USA, 1988; pp. 531-545.
4. Clarkson, T.W.; Magos, L. The effect of sodium maleate on the renal deposition and excretion of mercury. Br. J. Pharmacol. Chemother. 1967, 31, 560-567. [CrossRef] [PubMed]
5. Magos, L.; Stoytchev, T. Combined effect of sodium maleate and some thiol compounds on mercury excretion and redistribution in rats. Br. J. Pharmacol. 1969, 35, 121-126. [CrossRef] [PubMed]
6. Trojanowska, B.; Piotrowski, J.K.; Szendzikowski, S. The influence of thioacetamide on the excretion of mercury in rats. Toxicol. Appl. Pharmacol. 1971, 18, 374-386. [CrossRef]
7. Hall, R.L.; Wilke, W.L.; Fettman, M.J. Renal resistance to mercuric chloride toxicity during prolonged exposure in rats. Vet. Hum. Toxicol. 1986, 28, 305-307. [PubMed]
8. Eto, K.; Yasutake, A.; Miyamoto, K.; Tokunaga, H.; Otsuka, Y. Chronic effects of methylmercury in rats. II. Pathological aspects. Tohoku J. Exp. Med. 1997, 182, 197-205. [CrossRef] [PubMed]
9. Miller, S.; Pallan, S.; Gangji, A.S.; Lukic, D.; Clase, C.M. Mercury-associated nephrotic syndrome: A case report and systematic review of the literature. Am. J. Kidney Dis. 2013, 62, 135-138. [CrossRef] [PubMed]
10. Vanholder, R.C.; Praet, M.M.; Pattyn, P.A.; Leusen, I.R.; Lameire, N.H. Dissociation of glomerular filtration and renal blood flow in HgCl2-induced acute renal failure. Kidney Int. 1982, 22, 162-170. [CrossRef] [PubMed]
11. Houser, M.T.; Berndt, W.O. The effect of unilateral nephrectomy on the nephrotoxicity of mercuric chloride in the rat. Toxicol. Appl. Pharmacol. 1986, 83, 506-515. [CrossRef]
12. Houser, M.T.; Berndt,W.O. Unilateral nephrectomy in the rat: Effects on mercury handling and renal cortical subcellular distribution. Toxicol. Appl. Pharmacol. 1988, 93, 187-194. [CrossRef]
13. Ramos-Frendo, B.; Perez-Garcia, R.; Lopez-Novoa, J.M.; Hernando-Avendano, L. Increased severity of the acute renal failure induced by HgCl2 on rats with reduced renal mass. Biomedicine 1979, 31, 167-170. [PubMed]
14. Zalups, R.K. Autometallographic localization of inorganic mercury in the kidneys of rats: Effect of unilateral nephrectomy and compensatory renal growth. Exp. Mol. Pathol. 1991, 54, 10-21. [CrossRef]
15. Zalups, R.K. Enhanced renal outer medullary uptake of mercury associated with uninephrectomy:Implication of a luminal mechanism. J. Toxicol. Environ. Health 1997, 50, 173-194. [CrossRef] [PubMed]
16. Zalups, R.K.; Barfuss, D.W.; Kostyniak, P.J. Altered intrarenal accumulation of mercury in uninephrectomized rats treated with methylmercury chloride. Toxicol. Appl. Pharmacol. 1992, 115, 174-182. [CrossRef]
17. Zalups, R.K.; Klotzbach, J.M.; Diamond, G.L. Enhanced accumulation of injected inorganic mercury in renal outer medulla after unilateral nephrectomy. Toxicol. Appl. Pharmacol. 1987, 89, 226-236. [CrossRef]
18. 2+in Isolated S2 Proximal Tubular Segments. Toxicol. Sci. 2016, 154, 278-288. [CrossRef] [PubMed]
19. Zalups, R.K.; Bridges, C.C. Seventy-five percent nephrectomy and the disposition of inorganic mercury in 2,3-dimercaptopropanesulfonic acid-treated rats lacking functional multidrug-resistance protein 2. J. Pharmacol. Exp. Ther. 2010, 332, 866-875. [CrossRef] [PubMed]
20. Centers for Disease Control and Prevention (CDC). Chronic Kidney Disease Surveillance System-United States. Available online: www.cdc.gov/ckd (accessed on 16 September 2016).
21. Centers for Disease Control and Prevention (CDC). Summary Health Statistics: National Health Interview Survey; U.S. Department of Human and Heath Services; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2014.
22. Jha, V.; Garcia-Garcia, G.; Iseki, K.; Li, Z.; Naicker, S.; Plattner, B.; Saran, R.; Wang, A.Y.; Yang, C.W. Chronic kidney disease: Global dimension and perspectives. Lancet 2013, 382, 260-272. [CrossRef]
23. Centers of Disease Control and Prevention (CDC). National Chronic Kidney Disease Fact Sheet: General Information and National Estimates on Chronic Kidney Disease in the United States; US Department of Heath and Human Services: Atlanta, GA, USA, 2014.
24. Fine, L.G.; Norman, J.T.; Kujubu, D.A.; Knecht, A. Renal Hypertrophy. In The Kidney: Physiology and Pathophysiology, 2nd ed.; Seldin, D.W., Giebisch, G., Eds.; Raven Press: New York, NY, USA, 1992; pp. 3113-3133.
25. Salehmoghaddam, S.; Bradley, T.; Mikhail, N.; Badie-Dezfooly, B.; Nord, E.P.; Trizna, W.; Kheyfets, R.; Fine, L.G. Hypertrophy of basolateral Na-K pump activity in the proximal tubule of the remnant kidney. Lab. Investig. 1985, 53, 443-452. [PubMed]
26. Toback, F.G.; Smith, P.D.; Lowenstein, L.M. Phospholipid metabolism in the initiation of renal compensatory growth after acute reduction of renal mass. J. Clin. Investig. 1974, 54, 91-97. [CrossRef] [PubMed]
27. Wolf, G. Cellular mechanisms of tubule hypertrophy and hyperplasia in renal injury. Miner Electrolyte Metab. 1995, 21, 303-316. [PubMed]
28. Bricker, N.S.; Fine, L.G. The Renal Response to Progressive Nephron Loss. In The Kidney, 2nd ed.; Brenner, B.M., Rector, F.C., Eds.; Saunders: Philadelphia, PA, USA, 1981; Volume 1, pp. 1056-1096.
29. Klahr, S. Progression of chronic renal disease. Nutrition 1990, 6, 207-212. [PubMed]
30. Fine, L.G.; Norman, J. Cellular events in renal hypertrophy. Annu. Rev. Physiol. 1989, 51, 19-32. [CrossRef] [PubMed]
31. Lopez-Novoa, J.M. The Mechanisms of Age-Associated Glomerular Sclerosis. In The Aging Kidney in Health and Disease; Macias Nunez, J.F., Cameron, J.S., Oreopoulos, D.G., Eds.; Springer: New York, NY, USA, 2008; pp. 113-126.
32. Roels, H.A.; Lauwerys, R.R.; Bernard, A.M.; Buchet, J.P.; Vos, A.; Oversteyns, M. Assessment of the filtration reserve capacity of the kidney in workers exposed to cadmium. Br. J. Ind. Med. 1991, 48, 365-374. [CrossRef] [PubMed]
33. Uriu, K.; Kaizu, K.; Qie, Y.L.; Ito, A.; Takagi, I.; Suzuka, K.; Inada, Y.; Hashimoto, O.; Eto, S. Long-term oral intake of low-dose cadmium exacerbates age-related impairment of renal functional reserve in rats. Toxicol. Appl. Pharmacol. 2000, 169, 151-158. [CrossRef] [PubMed]
34. Zalups, R.K. Reductions in renal mass and the nephropathy induced by mercury. Toxicol. Appl. Pharmacol. 1997, 143, 366-379. [CrossRef] [PubMed]
35. Agency for Toxic Substances and Disease Registry (ATSDR). Public Health Statement: Arsenic; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2007.
36. Sattar, A.; Xie, S.; Hafeez, M.A.;Wang, X.; Hussain, H.I.; Iqbal, Z.; Pan, Y.; Iqbal, M.; Shabbir, M.A.; Yuan, Z. Metabolism and toxicity of arsenicals in mammals. Environ. Toxicol. Pharmacol. 2016, 48, 214-224. [CrossRef] [PubMed]
37. Thomas, D.J.; Styblo,M.; Lin, S. The cellularmetabolismand systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 2001, 176, 127-144. [CrossRef] [PubMed]
38. Calatayud, M.; Barrios, J.A.; Velez, D.; Devesa, V. In vitro study of transporters involved in intestinal absorption of inorganic arsenic. Chem. Res. Toxicol. 2012, 25, 446-453. [CrossRef] [PubMed]
39. Tseng, W.P.; Chu, H.M.; How, S.W.; Fong, J.M.; Lin, C.S.; Yeh, S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 1968, 40, 453-463. [PubMed]
40. Engel, R.R.; Hopenhayn-Rich, C.; Receveur, O.; Smith, A.H. Vascular effects of chronic arsenic exposure:A review. Epidemiol. Rev. 1994, 16, 184-209. [CrossRef] [PubMed]
41. Sung, T.C.; Huang, J.W.; Guo, H.R. Association between Arsenic Exposure and Diabetes: A Meta-Analysis. BioMed Res. Int. 2015, 2015, 368087. [CrossRef] [PubMed]
42. Sengupta, S.R.; Das, N.K.; Datta, P.K. Pathogenesis, clinical features and pathology of chronic arsenicosis. Indian J. Dermatol. Venereol. Leprol. 2008, 74, 559-570. [PubMed]
43. Lin, S.; Shi, Q.; Nix, F.B.; Styblo, M.; Beck, M.A.; Herbin-Davis, K.M.; Hall, L.L.; Simeonsson, J.B.; Thomas, D.J. A novel S-adenosyl-L-methionine: Arsenic(III) methyltransferase from rat liver cytosol. J. Biol. Chem. 2002, 277, 10795-10803. [CrossRef] [PubMed]
44. Healy, S.M.; Casarez, E.A.; Ayala-Fierro, F.; Aposhian, H. Enzymatic methylation of arsenic compounds. V. Arsenite methyltransferase activity in tissues of mice. Toxicol. Appl. Pharmacol. 1998, 148, 65-70. [CrossRef] [PubMed]
45. Thomas, D.J.; Li, J.;Waters, S.B.; Xing,W.; Adair, B.M.; Drobna, Z.; Devesa, V.; Styblo, M. Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals. Exp. Biol. Med. 2007, 232, 3-13.
46. Petrick, J.S.; Ayala-Fierro, F.; Cullen, W.R.; Carter, D.E.; Vasken Aposhian, H. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 2000, 163, 203-207. [CrossRef] [PubMed]
47. Styblo, M.; Del Razo, L.M.; Vega, L.; Germolec, D.R.; LeCluyse, E.L.; Hamilton, G.A.; Reed, W.; Wang, C.; Cullen, W.R.; Thomas, D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 2000, 74, 289-299. [CrossRef] [PubMed]
48. Mass, M.J.; Tennant, A.; Roop, B.C.; Cullen, W.R.; Styblo, M.; Thomas, D.J.; Kligerman, A.D. Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol. 2001, 14, 355-361. [CrossRef] [PubMed]
49. Styblo, M.; Serves, S.V.; Cullen, W.R.; Thomas, D.J. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 1997, 10, 27-33. [CrossRef] [PubMed]
50. Chouchane, S.; Snow, E.T. In vitro effect of arsenical compounds on glutathione-related enzymes. Chem. Res. Toxicol. 2001, 14, 517-522. [CrossRef] [PubMed]
51. Lin, S.; Del Razo, L.M.; Styblo, M.; Wang, C.; Cullen, W.R.; Thomas, D.J. Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chem. Res. Toxicol. 2001, 14, 305-311. [CrossRef] [PubMed]
52. Lin, S.; Cullen, W.R.; Thomas, D.J. Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem. Res. Toxicol. 1999, 12, 924-930. [CrossRef] [PubMed]
53. Petrick, J.S.; Jagadish, B.; Mash, E.A.; Aposhian, H.V. Monomethylarsonous acid (MMA(III)) and arsenite:LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 2001, 14, 651-656. [CrossRef] [PubMed]
54. Fowler, B.A.; Chou, S.J.; Jones, R.L.; Chen, C.J. Arsenic. In Handbook on the Toxicology of Metals, 3rd ed.; Nordberg, G.F., Fowler, B.A., Nordberg, M., Freiberg, L., Eds.; Elsevier: Amsterdam, The Netherlands, 2007; pp. 367-443.
55. Liu, Z.; Sanchez, M.A.; Jiang, X.; Boles, E.; Landfear, S.M.; Rosen, B.P. Mammalian glucose permease GLUT1 facilitates transport of arsenic trioxide and methylarsonous acid. Biochem. Biophys. Res. Commun. 2006, 351, 424-430. [CrossRef] [PubMed]
56. Sugawara-Yokoo, M.; Suzuki, T.; Matsuzaki, T.; Naruse, T.; Takata, K. Presence of fructose transporter GLUT5 in the S3 proximal tubules in the rat kidney. Kidney Int. 1999, 56, 1022-1028. [CrossRef] [PubMed]
57. Dominguez, J.H.; Camp, K.; Maianu, L.; Garvey,W.T. Glucose transporters of rat proximal tubule: Differential expression and subcellular distribution. Am. J. Physiol. 1992, 262, F807-F812. [PubMed]
58. Lee, T.C.; Ho, I.C.; Lu,W.J.; Huang, J.D. Enhanced expression of multidrug resistance-associated protein 2 and reduced expression of aquaglyceroporin 3 in an arsenic-resistant human cell line. J. Biol. Chem. 2006, 281, 18401-18407. [CrossRef] [PubMed]
59. Bedford, J.J.; Leader, J.P.;Walker, R.J. Aquaporin expression in normal human kidney and in renal disease. J. Am. Soc. Nephrol. 2003, 14, 2581-2587. [CrossRef] [PubMed]
60. Lu, W.J.; Tamai, I.; Nezu, J.; Lai, M.L.; Huang, J.D. Organic anion transporting polypeptide-C mediates arsenic uptake in HEK-293 cells. J. Biomed. Sci. 2006, 13, 525-533. [CrossRef] [PubMed]
61. Aleksunes, L.M.; Augustine, L.M.; Scheffer, G.L.; Cherrington, N.J.; Manautou, J.E. Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment. Toxicology 2008, 250, 82-88. [CrossRef] [PubMed]
62. Roggenbeck, B.A.; Banerjee, M.; Leslie, E.M. Cellular arsenic transport pathways in mammals. J. Environ. Sci. 2016, 49, 38-58. [CrossRef] [PubMed]
63. Kala, S.V.; Kala, G.; Prater, C.I.; Sartorelli, A.C.; Lieberman, M.W. Formation and urinary excretion of arsenic triglutathione and methylarsenic diglutathione. Chem. Res. Toxicol. 2004, 17, 243-249. [CrossRef] [PubMed]
64. Roggenbeck, B.A.; Carew, M.W.; Charrois, G.J.; Douglas, D.N.; Kneteman, N.M.; Lu, X.; Le, X.C.; Leslie, E.M. Characterization of arsenic hepatobiliary transport using sandwich-cultured human hepatocytes. Toxicol. Sci. 2015, 145, 307-320. [CrossRef] [PubMed]
65. Yehiayan, L.; Stice, S.; Liu, G.; Matulis, S.; Boise, L.H.; Cai, Y. Dimethylarsinothioyl glutathione as a metabolite in human multiple myeloma cell lines upon exposure to Darinaparsin. Chem. Res. Toxicol. 2014, 27, 754-764. [CrossRef] [PubMed]
66. Thomas, D.J. Unraveling arsenic-Glutathione connections. Toxicol. Sci. 2009, 107, 309-311. [CrossRef] [PubMed]
67. Scott, N.; Hatlelid, K.M.; MacKenzie, N.E.; Carter, D.E. Reactions of arsenic(III) and arsenic(V) species with glutathione. Chem. Res. Toxicol. 1993, 6, 102-106. [CrossRef] [PubMed]
68. Delnomdedieu, M.; Basti, M.M.; Styblo, M.; Otvos, J.D.; Thomas, D.J. Complexation of arsenic species in rabbit erythrocytes. Chem. Res. Toxicol. 1994, 7, 621-627. [CrossRef] [PubMed]
69. Liu, J.; Chen, H.; Miller, D.S.; Saavedra, J.E.; Keefer, L.K.; Johnson, D.R.; Klaassen, C.D.; Waalkes, M.P. Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. Mol. Pharmacol. 2001, 60, 302-309. [PubMed]
70. Vernhet, L.; Seite, M.P.; Allain, N.; Guillouzo, A.; Fardel, O. Arsenic induces expression of the multidrug resistance-associated protein 2 (MRP2) gene in primary rat and human hepatocytes. J. Pharmacol. Exp. Ther. 2001, 298, 234-239. [PubMed]
71. Drobna, Z.; Walton, F.S.; Paul, D.S.; Xing, W.; Thomas, D.J.; Styblo, M. Metabolism of arsenic in human liver:The role of membrane transporters. Arch. Toxicol. 2010, 84, 3-16. [CrossRef] [PubMed]
72. Gao, Y.; Pei, Q.L.; Li, G.X.; Han, G.; Tian, F.J.; Qin, X.J.; Zhang, R.; Hou,W.S.; Li, X.Y. Effects of MRP2-GSH cotransport system on hepatic arsenic metabolism in rats. Chin. J. Ind. Hyg. Occup. Dis. 2006, 24, 278-280.
73. Leslie, E.M.; Deeley, R.G.; Cole, S.P. Multidrug resistance proteins: Role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol. Appl. Pharmacol. 2005, 204, 216-237. [CrossRef] [PubMed]
74. Carew, M.W.; Leslie, E.M. Selenium-dependent and -independent transport of arsenic by the human multidrug resistance protein 2 (MRP2/ABCC2): Implications for the mutual detoxification of arsenic and selenium. Carcinogenesis 2010, 31, 1450-1455. [CrossRef] [PubMed]
75. Banerjee, M.; Carew, M.W.; Roggenbeck, B.A.; Whitlock, B.D.; Naranmandura, H.; Le, X.C.; Leslie, E.M. A novel pathway for arsenic elimination: Human multidrug resistance protein 4 (MRP4/ABCC4) mediates cellular export of dimethylarsinic acid (DMAV) and the diglutathione conjugate of monomethylarsonous acid (MMAIII). Mol. Pharmacol. 2014, 86, 168-179. [CrossRef] [PubMed]
76. Kimura, A.; Ishida, Y.; Hayashi, T.; Wada, T.; Yokoyama, H.; Sugaya, T.; Mukaida, N.; Kondo, T. Interferon-gamma plays protective roles in sodium arsenite-induced renal injury by up-regulating intrarenal multidrug resistance-associated protein 1 expression. Am. J. Pathol. 2006, 169, 1118-1128. [CrossRef] [PubMed]
77. Chin, K.V.; Tanaka, S.; Darlington, G.; Pastan, I.; Gottesman, M.M. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem. 1990, 265, 221-226. [PubMed]
78. Liu, J.; Liu, Y.; Powell, D.A.; Waalkes, M.P.; Klaassen, C.D. Multidrug-resistance mdr1a/1b double knockout mice are more sensitive than wild type mice to acute arsenic toxicity, with higher arsenic accumulation in tissues. Toxicology 2002, 170, 55-62. [CrossRef]
79. Xie, Y.; Liu, J.; Liu, Y.; Klaassen, C.D.;Waalkes, M.P. Toxicokinetic and genomic analysis of chronic arsenic exposure in multidrug-resistance mdr1a/1b(-/-) double knockout mice. Mol. Cell. Biochem. 2004, 255, 11-18. [CrossRef] [PubMed]
80. George, B.; You, D.; Joy, M.S.; Aleksunes, L.M. Xenobiotic transporters and kidney injury. Adv. Drug Deliv. Rev. 2017. [CrossRef] [PubMed]
81. Yang, H.; Guo, D.; Obianom, O.N.; Su, T.; Polli, J.E.; Shu, Y. Multidrug and toxin extrusion proteins mediate cellular transport of cadmium. Toxicol. Appl. Pharmacol. 2017, 314, 55-62. [CrossRef] [PubMed]
82. Prasad, G.V.; Rossi, N.F. Arsenic intoxication associated with tubulointerstitial nephritis. Am. J. Kidney Dis. 1995, 26, 373-376. [CrossRef]
83. Robles-Osorio, M.L.; Sabath-Silva, E.; Sabath, E. Arsenic-mediated nephrotoxicity. Ren. Fail. 2015, 37, 542-547. [CrossRef] [PubMed]
84. Tsao, D.A.; Tseng, W.C.; Chang, H.R. RKIP expression of liver and kidney after arsenic exposure. Environ. Toxicol. 2017, 32, 1079-1082. [CrossRef] [PubMed]
85. Yeung, K.; Seitz, T.; Li, S.; Janosch, P.; McFerran, B.; Kaiser, C.; Fee, F.; Katsanakis, K.D.; Rose, D.W.; Mischak, H.; et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 1999, 401, 173-177. [PubMed]
86. Yeung, K.; Janosch, P.; McFerran, B.; Rose, D.W.; Mischak, H.; Sedivy, J.M.; Kolch, W. Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Mol. Cell. Biol. 2000, 20, 3079-3085. [CrossRef] [PubMed]
87. Odabaei, G.; Chatterjee, D.; Jazirehi, A.R.; Goodglick, L.; Yeung, K.; Bonavida, B. Raf-1 kinase inhibitor protein: Structure, function, regulation of cell signaling, and pivotal role in apoptosis. Adv. Cancer Res. 2004, 91, 169-200. [PubMed]
88. Singh, R.D.; Tiwari, R.; Khan, H.; Kumar, A.; Srivastava, V. Arsenic exposure causes epigenetic dysregulation of IL-8 expression leading to proneoplastic changes in kidney cells. Toxicol. Lett. 2015, 237, 1-10. [CrossRef] [PubMed]
89. Verdugo, M.; Ogra, Y.; Quiroz,W. Mechanisms underlying the toxic effects of antimony species in human embryonic kidney cells (HEK-293) and their comparison with arsenic species. J. Toxicol. Sci. 2016, 41, 783-792. [CrossRef] [PubMed]
90. Sinha, M.; Manna, P.; Sil, P.C. Arjunolic acid attenuates arsenic-induced nephrotoxicity. Pathophysiology 2008, 15, 147-156. [CrossRef] [PubMed]
91. Roy, A.; Manna, P.; Sil, P.C. Prophylactic role of taurine on arsenic mediated oxidative renal dysfunction via MAPKs/ NF-kappaB and mitochondria dependent pathways. Free Radic. Res. 2009, 43, 995-1007. [CrossRef] [PubMed]
92. Gong, X.; Ivanov, V.N.; Davidson, M.M.; Hei, T.K. Tetramethylpyrazine (TMP) protects against sodium arsenite-induced nephrotoxicity by suppressing ROS production, mitochondrial dysfunction, pro-inflammatory signaling pathways and programed cell death. Arch. Toxicol. 2015, 89, 1057-1070. [CrossRef] [PubMed]
93. Orihuela, R.; Kojima, C.; Tokar, E.J.; Person, R.J.; Xu, Y.; Qu, W.; Waalkes, M.P. Oxidative DNA damage after acute exposure to arsenite and monomethylarsonous acid in biomethylation-deficient human cells. Toxicol. Mech. Methods 2013, 23, 389-395. [CrossRef] [PubMed]
94. Sasaki, A.; Oshima, Y.; Fujimura, A. An approach to elucidate potential mechanism of renal toxicity of arsenic trioxide. Exp. Hematol. 2007, 35, 252-262. [CrossRef] [PubMed]
95. Peraza, M.A.; Carter, D.E.; Gandolfi, A.J. Toxicity and metabolism of subcytotoxic inorganic arsenic in human renal proximal tubule epithelial cells (HK-2). Cell Biol. Exp. Toxicol. 2003, 19, 253-264. [CrossRef]
96. Lee, C.H.; Yu, H.S. Role of mitochondria, ROS, and DNA damage in arsenic induced carcinogenesis. Front. Biosci. 2016, 8, 312-320.
97. Ganger, R.; Garla, R.; Mohanty, B.P.; Bansal, M.P.; Garg, M.L. Protective Effects of Zinc Against Acute Arsenic Toxicity by Regulating Antioxidant Defense System and Cumulative Metallothionein Expression. Biol. Trace Elem. Res. 2016, 169, 218-229. [CrossRef] [PubMed]
98. Cui, X.; Okayasu, R. Arsenic accumulation, elimination, and interaction with copper, zinc and manganese in liver and kidney of rats. Food Chem. Toxicol. 2008, 46, 3646-3650. [CrossRef] [PubMed]
99. Kreppel, H.; Bauman, J.W.; Liu, J.; McKim, J.M., Jr.; Klaassen, C.D. Induction of metallothionein by arsenicals in mice. Fundam. Appl. Toxicol. 1993, 20, 184-189. [CrossRef] [PubMed]
100. Garla, R.; Mohanty, B.P.; Ganger, R.; Sudarshan, M.; Bansal, M.P.; Garg, M.L. Metal stoichiometry of isolated and arsenic substituted metallothionein: PIXE and ESI-MS study. Biometals 2013, 26, 887-896. [CrossRef] [PubMed]
101. 3+-thiol model compounds: Implication for the core structure of As(III)-metallothionein. J. Mol. Model. 2017, 23, 78. [CrossRef] [PubMed]
102. Qu,W.;Waalkes, M.P. Metallothionein blocks oxidative DNA damage induced by acute inorganic arsenic exposure. Toxicol. Appl. Pharmacol. 2015, 282, 267-274. [CrossRef] [PubMed]
103. Garla, R.; Ganger, R.; Mohanty, B.P.; Verma, S.; Bansal, M.P.; Garg, M.L. Metallothionein does not sequester arsenic(III) ions in condition of acute arsenic toxicity. Toxicology 2016, 366-367, 68-73. [CrossRef] [PubMed]
104. Weidemann, D.; Kuo, C.C.; Navas-Acien, A.; Abraham, A.G.; Weaver, V.; Fadrowski, J. Association of arsenic with kidney function in adolescents and young adults: Results from the National Health and Nutrition Examination Survey 2009-2012. Environ. Res. 2015, 140, 317-324. [CrossRef] [PubMed]
105. Hsueh, Y.M.; Chung, C.J.; Shiue, H.S.; Chen, J.B.; Chiang, S.S.; Yang, M.H.; Tai, C.W.; Su, C.T. Urinary arsenic species and CKD in a Taiwanese population: A case-control study. Am. J. Kidney Dis. 2009, 54, 859-870. [CrossRef] [PubMed]
106. Vaziri, N.D.; Upham, T.; Barton, C.H. Hemodialysis clearance of arsenic. Clin. Toxicol. 1980, 17, 451-456. [CrossRef] [PubMed]
107. Zheng, L.Y.; Umans, J.G.; Yeh, F.; Francesconi, K.A.; Goessler, W.; Silbergeld, E.K.; Bandeen-Roche, K.; Guallar, E.; Howard, B.V.;Weaver, V.M.; et al. The association of urine arsenic with prevalent and incident chronic kidney disease: Evidence from the Strong Heart Study. Epidemiology 2015, 26, 601-612. [CrossRef] [PubMed]
108. Faroon, O.; Ashizawa, A.;Wright, S.; Tucker, P.; Jenkins, K.; Ingerman, L.; Rudisill, C. Toxicological Profile for Cadmium. In U.S. Department of Health and Human Services, Public Health Service; Centers for Disease Control and Prevention; Agency for Toxic Substances and Disease Registry (ATSDR): Atlanta, GA, USA, 2008.
109. World Health Organization (WHO). Cadmium-Environmental Health Criteria 134; World Health Organization (WHO): Geneva, Switzerland, 1992.
110. Friberg, L.; Piscator, M.; Nordberg, G.; Kjellstrom, T. Cadmium in the Environmnent, 2nd ed.; CRC Press:Cleveland, OH, USA, 1974.
111. Elinder, C.G.; Kjellstrom, T.; Lind, B.; Linnman, L.; Piscator, M.; Sundstedt, K. Cadmium exposure from smoking cigarettes: Variations with time and country where purchased. Environ. Res. 1983, 32, 220-227. [CrossRef]
112. Elinder, C.G.; Lind, B.; Kjellstrom, T.; Linnman, L.; Friberg, L. Cadmium in kidney cortex, liver, and pancreas from Swedish autopsies. Estimation of biological half time in kidney cortex, considering calorie intake and smoking habits. Arch. Environ. Health 1976, 31, 292-302. [CrossRef] [PubMed]
113. Jarup, L.; Berglund,M.; Elinder, C.G.; Nordberg, G.; Vahter,M. Health effects of cadmium exposure-A review of the literature and a risk estimate. Scand. J. Work Environ. Health 1998, 24 (Suppl. S1), 1-51. [PubMed]
114. Olsson, I.M.; Bensryd, I.; Lundh, T.; Ottosson, H.; Skerfving, S.; Oskarsson, A. Cadmium in blood and urine-Impact of sex, age, dietary intake, iron status, and former smoking-Association of renal effects. Environ. Health Perspect. 2002, 110, 1185-1190. [CrossRef] [PubMed]
115. Centers for Disease Control (CDC); Community Futures Development Corporation (CFDC). Fourth National Report on Human Exposure to Environmental Chemicals; Centers for Disease Control (CDC): Atlanta, GA, USA, 2009; pp. 218-226.
116. Rabenstein, D.L.; Isab, A.A.; Kadima, W.; Mohanakrishnan, P. A proton nuclear magnetic resonance study of the interaction of cadmium with human erythrocytes. Biochim. Biophys. Acta 1983, 762, 531-541. [CrossRef]
117. Rabenstein, D.L. Metal complexes of glutathione and their biological significance. In Glutathione: Chemical, Biochemical and Medical Aspects, Coenzymes and Cofactors; Dolphin, D., Auromovibic, O., Poulson, R., Eds.; Wiley: New York, NY, USA, 1989; Volume 3, pp. 147-186.
118. Wang, Y.; Zalups, R.K.; Barfuss, D.W. Potential mechanisms involved in the absorptive transport of cadmium in isolated perfused rabbit renal proximal tubules. Toxicol. Lett. 2010, 193, 61-68. [CrossRef] [PubMed]
119. Zalups, R.K.; Ahmad, S. Molecular handling of cadmium in transporting epithelia. Toxicol. Appl. Pharmacol. 2003, 186, 163-188. [CrossRef]
120. Soodvilai, S.; Nantavishit, J.; Muanprasat, C.; Chatsudthipong, V. Renal organic cation transporters mediated cadmium-induced nephrotoxicity. Toxicol. Lett. 2011, 204, 38-42. [CrossRef] [PubMed]
121. 2+. Mol. Pharm. 2013, 10, 3045-3056. [CrossRef] [PubMed]
122. Sweet, D.H.; Miller, D.S.; Pritchard, J.B. Basolateral localization of organic cation transporter 2 in intact renal proximal tubules. Am. J. Physiol. Ren. Physiol. 2000, 279, F826-F834.
123. Karbach, U.; Kricke, J.; Meyer-Wentrup, F.; Gorboulev, V.; Volk, C.; Loffing-Cueni, D.; Kaissling, B.; Bachmann, S.; Koepsell, H. Localization of organic cation transporters OCT1 and OCT2 in rat kidney. Am. J. Physiol. Ren. Physiol. 2000, 279, F679-F687.
124. Felley-Bosco, E.; Diezi, J. Fate of cadmium in rat renal tubules: A micropuncture study. Toxicol. Appl. Pharmacol. 1989, 98, 243-251. [CrossRef]
125. Barbier, O.; Jacquillet, G.; Tauc, M.; Poujeol, P.; Cougnon, M. Acute study of interaction among cadmium, calcium, and zinc transport along the rat nephron in vivo. Am. J. Physiol. Ren. Physiol. 2004, 287, F1067-F1075. [CrossRef] [PubMed]
126. Dudley, R.E.; Gammal, L.M.; Klaassen, C.D. Cadmium-induced hepatic and renal injury in chronically exposed rats: Likely role of hepatic cadmium-metallothionein in nephrotoxicity. Toxicol. Appl. Pharmacol. 1985, 77, 414-426. [CrossRef]
127. 2+or CdMT in proximal tubule cells: Different uptake routes and permissive role of endo/lysosomal CdMT uptake. Am. J. Physiol. Cell Physiol. 2003, 285, C1367-C1376. [CrossRef] [PubMed]
128. Murakami, M.; Sano, K.; Webb, M. The effect of L-cysteine on the portion-selective uptake of cadmium in the renal proximal tubule. Arch. Toxicol. 1987, 60, 365-369. [CrossRef] [PubMed]
129. Dorian, C.; Gattone, V.H., 2nd; Klaassen, C.D. Accumulation and degradation of the protein moiety of cadmium-metallothionein (CdMT) in the mouse kidney. Toxicol. Appl. Pharmacol. 1992, 117, 242-248. [CrossRef]
130. Dorian, C.; Gattone, V.H., 2nd; Klaasen, C.D. Renal cadmium deposition and injury as a result of accumulation of cadmium-metallothionein (CdMT) by the proximal convoluted tubules-A light microscopic autoradiography study with 109CdMT. Toxicol. Appl. Pharmacol. 1992, 114, 173-181. [CrossRef]
131. Foulkes, E.C. Renal tubular transport of cadmium-metallothionein. Toxicol. Appl. Pharmacol. 1978, 45, 505-512. [CrossRef]
132. Nordberg, M.; Jin, T.; Nordberg, G.F. Cadmium, metallothionein and renal tubular toxicity. IARC Sci. Publ. 1992, 118, 293-297.
133. Webb, M. Role of metallothionein in cadmium metabolism. In Cadmium; Foulkes, E.C., Ed.; Springer: Berlin, Germany; New York, NY, USA, 1986.
134. Thevenod, F. Catch me if you can! Novel aspects of cadmium transport in mammalian cells. Biometals 2010, 23, 857-875. [CrossRef] [PubMed]
135. Thevenod, F. Nephrotoxicity and the proximal tubule. Insights from cadmium. Nephron Physiol. 2003, 93, 87-93. [CrossRef]
136. Nordberg, G.F.; Goyer, R.; Nordberg, M. Comparative toxicity of cadmium-metallothionein and cadmium chloride on mouse kidney. Arch. Pathol. 1975, 99, 192-197. [PubMed]
137. Cherian, M.G.; Nordberg, M. Cellular adaptation in metal toxicology and metallothionein. Toxicology 1983, 28, 1-15. [PubMed]
138. Felley-Bosco, E.; Diezi, J. Fate of cadmium in rat renal tubules: A microinjection study. Toxicol. Appl. Pharmacol. 1987, 91, 204-211. [PubMed]
139. Murakami, M.; Cain, K.; Webb, M. Cadmium-metallothionein-induced nephropathy: A morphological and autoradiographic study of cadmium distribution, the development of tubular damage and subsequent cell regeneration. J. Appl. Toxicol. 1983, 3, 237-244. [PubMed]
140. Zalups, R.K.; Gelein, R.M.; Cherian, M.G. Shifts in the dose-effect relationship for the nephropathy induced by cadmium-metallothionein in rats after a reduction in renal mass. J. Pharmacol. Exp. Ther. 1992, 262, 1256-1266. [PubMed]
141. Abouhamed, M.; Wolff, N.A.; Lee, W.K.; Smith, C.P.; Thevenod, F. Knockdown of endosomal/lysosomal divalent metal transporter 1 by RNA interference prevents cadmium-metallothionein-1 cytotoxicity in renal proximal tubule cells. Am. J. Physiol. Ren. Physiol. 2007, 293, F705-F712.
142. Ferguson, C.J.; Wareing, M.; Ward, D.T.; Green, R.; Smith, C.P.; Riccardi, D. Cellular localization of divalent metal transporter DMT-1 in rat kidney. Am. J. Physiol. Ren. Physiol. 2001, 280, F803-F814.
143. Scheuhammer, A.M.; Cherian, M.G. Quantification of metallothioneins by a silver-saturation method. Toxicol. Appl. Pharmacol. 1986, 82, 417-425. [PubMed]
144. Wang, B.; Schneider, S.N.; Dragin, N.; Girijashanker, K.; Dalton, T.P.; He, L.; Miller, M.L.; Stringer, K.F.; Soleimani, M.; Richardson, D.D.; et al. Enhanced cadmium-induced testicular necrosis and renal proximal tubule damage caused by gene-dose increase in a Slc39a8-transgenic mouse line. Am. J. Physiol. Cell Physiol. 2007, 292, C1523-C1535. [PubMed]
145. Girijashanker, K.; He, L.; Soleimani, M.; Reed, J.M.; Li, H.; Liu, Z.; Wang, B.; Dalton, T.P.; Nebert, D.W. Slc39a14 gene encodes ZIP14, a metal/bicarbonate symporter: Similarities to the ZIP8 transporter. Mol. Pharmacol. 2008, 73, 1413-1423. [PubMed]
146. Fujishiro, H.; Okugaki, S.; Kubota, K.; Fujiyama, T.; Miyataka, H.; Himeno, S. The role of ZIP8 down-regulation in cadmium-resistant metallothionein-null cells. J. Appl. Toxicol. 2009, 29, 367-373. [CrossRef] [PubMed]
147. Fujishiro, H.; Yano, Y.; Takada, Y.; Tanihara, M.; Himeno, S. Roles of ZIP8, ZIP14, and DMT1 in transport of cadmium and manganese in mouse kidney proximal tubule cells. Metallomics 2012, 4, 700-708. [CrossRef] [PubMed]
148. He, L.; Wang, B.; Hay, E.B.; Nebert, D.W. Discovery of ZIP transporters that participate in cadmium damage to testis and kidney. Toxicol. Appl. Pharmacol. 2009, 238, 250-257. [CrossRef] [PubMed]
149. Zhang, R.; Witkowska, K.; Afonso Guerra-Assuncao, J.; Ren, M.; Ng, F.L.; Mauro, C.; Tucker, A.T.; Caulfield, M.J.; Ye, S. A blood pressure-associated variant of the SLC39A8 gene influences cellular cadmium accumulation and toxicity. Hum. Mol. Genet. 2016, 25, 4117-4126. [CrossRef] [PubMed]
150. Otsuka, M.; Matsumoto, T.; Morimoto, R.; Arioka, S.; Omote, H.; Moriyama, Y. A human transporter protein that mediates the final excretion step for toxic organic cations. Proc. Natl. Acad. Sci. USA 2005, 102, 17923-17928. [CrossRef] [PubMed]
151. +/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2. J. Am. Soc. Nephrol. 2006, 17, 2127-2135. [CrossRef] [PubMed]
152. Carriere, P.; Mantha, M.; Champagne-Paradis, S.; Jumarie, C. Characterization of basolateral-to-apical transepithelial transport of cadmium in intestinal TC7 cell monolayers. Biometals 2011, 24, 857-874. [CrossRef] [PubMed]
153. Prozialeck,W.C.; Edwards, J.R. Early biomarkers of cadmium exposure and nephrotoxicity. Biometals 2010, 23, 793-809. [CrossRef] [PubMed]
154. Elinder, C.G.; Gerhardsson, L.; Oberdorster, G. Biological monitoring of toxic metals: Overview. In Biological Monitoring of Toxic Metals; Clarkson, T.W., Friberg, L., Nordberg, G.F., Sager, P.R., Eds.; Plenum Press: London, UK, 1988; pp. 1-71.
155. Nordberg, G.F.; Nogawa, K.; Nordberg, M.; Friedmann, J.M. Cadmium. In Handbook on the Toxicology of Metals; Nordberg, G.F., Fowler, B.A., Nordberg, M., Friberg, L., Eds.; Elsevier: Amsterdam, The Netherlands, 2007; pp. 445-486.
156. Nordberg, G.F.; Nordberg, M. Biological monitoring of cadmium. In Biological Monitoring of Toxic Metals; Clarkson, T.W., Friberg, L., Nordberg, G.F., Sager, P.R., Eds.; Plenum Press: New York, NY, USA, 2001; pp. 151-168.
157. Johri, N.; Jacquillet, G.; Unwin, R. Heavy metal poisoning: The effects of cadmium on the kidney. Biometals 2010, 23, 783-792. [CrossRef] [PubMed]
158. Prozialeck, W.C.; VanDreel, A.; Ackerman, C.D.; Stock, I.; Papaeliou, A.; Yasmine, C.; Wilson, K.; Lamar, P.C.; Sears, V.L.; Gasiorowski, J.Z.; et al. Evaluation of cystatin C as an early biomarker of cadmium nephrotoxicity in the rat. Biometals 2016, 29, 131-146. [CrossRef] [PubMed]
159. Akesson, A.; Lundh, T.; Vahter, M.; Bjellerup, P.; Lidfeldt, J.; Nerbrand, C.; Samsioe, G.; Stromberg, U.; Skerfving, S. Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ. Health Perspect. 2005, 113, 1627-1631. [CrossRef] [PubMed]
160. Tsuchiya, K.; Iwao, S.; Sugita, M.; Sakurai, H. Increased urinary beta 2-microglobulin in cadmium exposure:Dose-effect relationship and biological significance of beta 2-microglobulin. Environ. Health Perspect. 1979, 28, 147-153. [PubMed]
161. Jin, T.;Nordberg,G.;Wu, X.; Ye, T.; Kong,Q.;Wang, Z.; Zhuang, F.; Cai, S. Urinary N-acetyl-beta-D-glucosaminidase isoenzymes as biomarker of renal dysfunction caused by cadmium in a general population. Environ. Res. 1999, 81, 167-173. [CrossRef] [PubMed]
162. Prozialeck, W.C.; Vaidya, V.S.; Liu, J.; Waalkes, M.P.; Edwards, J.R.; Lamar, P.C.; Bernard, A.M.; Dumont, X.; Bonventre, J.V. Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity. Kidney Int. 2007, 72, 985-993. [CrossRef] [PubMed]
163. Jarup, L.; Alfven, T. Low level cadmium exposure, renal and bone effects-The OSCAR study. Biometals 2004, 17, 505-509. [CrossRef] [PubMed]
164. Jarup, L.; Hellstrom, L.; Alfven, T.; Carlsson, M.D.; Grubb, A.; Persson, B.; Pettersson, C.; Spang, G.; Schutz, A.; Elinder, C.G. Low level exposure to cadmium and early kidney damage: The OSCAR study. Occup. Environ. Med. 2000, 57, 668-672. [CrossRef] [PubMed]
165. Noonan, C.W.; Sarasua, S.M.; Campagna, D.; Kathman, S.J.; Lybarger, J.A.; Mueller, P.W. Effects of exposure to low levels of environmental cadmium on renal biomarkers. Environ. Health Perspect. 2002, 110, 151-155. [CrossRef] [PubMed]
166. Mortensen, M.E.; Wong, L.Y.; Osterloh, J.D. Smoking status and urine cadmium above levels associated with subclinical renal effects in U.S. adults without chronic kidney disease. Int. J. Hyg. Environ. Health 2011, 214, 305-310. [CrossRef] [PubMed]
167. Huang, M.; Choi, S.J.; Kim, D.W.; Kim, N.Y.; Park, C.H.; Yu, S.D.; Kim, D.S.; Park, K.S.; Song, J.S.; Kim, H.; et al. Risk assessment of low-level cadmium and arsenic on the kidney. J. Toxicol. Environ. Health A 2009, 72, 1493-1498. [CrossRef] [PubMed]
168. Sabolic, I.; Ljubojevic, M.; Herak-Kramberger, C.M.; Brown, D. Cd-MT causes endocytosis of brush-border transporters in rat renal proximal tubules. Am. J. Physiol. Ren. Physiol. 2002, 283, F1389-F1402. [CrossRef]
169. Herak-Kramberger, C.M.; Brown, D.; Sabolic, I. Cadmium inhibits vacuolar H(+)-ATPase and endocytosis in rat kidney cortex. Kidney Int. 1998, 53, 1713-1726. [CrossRef] [PubMed]
170. Wolff, N.A.; Abouhamed, M.; Verroust, P.J.; Thevenod, F. Megalin-dependent internalization of cadmium-metallothionein and cytotoxicity in cultured renal proximal tubule cells. J. Pharmacol. Exp. Ther. 2006, 318, 782-791. [CrossRef] [PubMed]
171. Santoyo-Sanchez, M.P.; Pedraza-Chaverri, J.; Molina-Jijon, E.; Arreola-Mendoza, L.; Rodriguez-Munoz, R.; Barbier, O.C. Impaired endocytosis in proximal tubule from subchronic exposure to cadmium involves angiotensin II type 1 and cubilin receptors. BMC Nephrol. 2013, 14, 211. [CrossRef] [PubMed]
172. Yang, L.Y.; Wu, K.H.; Chiu, W.T.; Wang, S.H.; Shih, C.M. The cadmium-induced death of mesangial cells results in nephrotoxicity. Autophagy 2009, 5, 571-572. [CrossRef] [PubMed]
173. Liu, Y.; Templeton, D.M. Cadmium activates CaMK-II and initiates CaMK-II-dependent apoptosis in mesangial cells. FEBS Lett. 2007, 581, 1481-1486. [CrossRef] [PubMed]
174. Jarup, L.; Persson, B.; Elinder, C.G. Decreased glomerular filtration rate in solderers exposed to cadmium. Occup. Environ. Med. 1995, 52, 818-822. [CrossRef] [PubMed]
175. Brzoska, M.M.; Kaminski, M.; Dziki, M.; Moniuszko-Jakoniuk, J. Changes in the structure and function of the kidney of rats chronically exposed to cadmium. II. Histoenzymatic studies. Arch. Toxicol. 2004, 78, 226-231. [PubMed]
176. Jarup, L.; Elinder, C.G. Incidence of renal stones among cadmium exposed battery workers. Br. J. Ind. Med. 1993, 50, 598-602. [CrossRef] [PubMed]
177. Aoshima, K.; Kasuya, M. Preliminary study on serum levels of 1,25-dihydroxyvitamin D and 25-hydroxyvitamin D in cadmium-induced renal tubular dysfunction. Toxicol. Lett. 1991, 57, 91-99. [PubMed]
178. Tsuritani, I.; Honda, R.; Ishizaki, M.; Yamada, Y.; Kido, T.; Nogawa, K. Impairment of vitamin D metabolism due to environmental cadmium exposure, and possible relevance to sex-related differences in vulnerability to the bone damage. J. Toxicol. Environ. Health 1992, 37, 519-533. [CrossRef] [PubMed]
179. Galazyn-Sidorczuk, M.; Brzoska, M.M.; Jurczuk, M.; Moniuszko-Jakoniuk, J. Oxidative damage to proteins and DNA in rats exposed to cadmium and/or ethanol. Chem. Biol. Interact. 2009, 180, 31-38. [CrossRef] [PubMed]
180. Matovic, V.; Buha, A.; Ethukic-Cosic, D.; Bulat, Z. Insight into the oxidative stress induced by lead and/or cadmium in blood, liver and kidneys. Food Chem. Toxicol. 2015, 78, 130-140. [CrossRef] [PubMed]
181. So, K.Y.; Oh, S.H. Cadmium-induced heme-oxygenase-1 expression plays dual roles in autophagy and apoptosis and is regulated by both PKC-delta and PKB/Akt activation in NRK52E kidney cells. Toxicology 2016, 370, 49-59. [CrossRef] [PubMed]
182. Chen, Z.; Gu, D.; Zhou, M.; Shi, H.; Yan, S.; Cai, Y. Regulatory role of miR-125a/b in the suppression by selenium of cadmium-induced apoptosis via the mitochondrial pathway in LLC-PK1 cells. Chem. Biol. Interact. 2016, 243, 35-44. [CrossRef] [PubMed]
183. Babaknejad, N.; Moshtaghie, A.A.; Nayeri, H.; Hani, M.; Bahrami, S. Protective Role of Zinc and Magnesium against Cadmium Nephrotoxicity in MaleWistar Rats. Biol. Trace Elem. Res. 2016, 174, 112-120. [CrossRef] [PubMed]
184. Lin, Y.S.; Ho,W.C.; Caffrey, J.L.; Sonawane, B. Low serum zinc is associated with elevated risk of cadmium nephrotoxicity. Environ. Res. 2014, 134, 33-38. [CrossRef] [PubMed]
185. Jihenel, H.; Imed, M.; Fatima, H.; Abdelhamid, K. Protective effects of selenium (Se) and zinc (Zn) on cadmium (Cd) toxicity in the liver and kidney of the rat: Histology and Cd accumulation. Food Chem. Toxicol. 2008, 46, 3522-3527. [CrossRef] [PubMed]
186. Liu, J.; Liu, Y.; Habeebu, S.S.; Klaassen, C.D. Metallothionein-null mice are highly susceptible to the hematotoxic and immunotoxic effects of chronic CdCl2 exposure. Toxicol. Appl. Pharmacol. 1999, 159, 98-108. [CrossRef] [PubMed]
187. Brzoska, M.M.; Roszczenko, A.; Galazyn-Sidorczuk, M.; Majewska, K. Zinc supplementation can protect from enhanced risk of femoral neck fracture in male rats chronically exposed to cadmium. Exp. Toxicol. Pathol. 2011, 63, 491-498. [CrossRef] [PubMed]
188. Jihenel, H.; Fatima, H.; Nouha, A.; Baati, T.; Imed, M.; Abdelhamid, K. Cadmium retention increase:A probable key mechanism of the protective effect of zinc on cadmium-induced toxicity in the kidney. Toxicol. Lett. 2010, 196, 104-109. [CrossRef] [PubMed]
189. Jacquillet, G.; Barbier, O.; Cougnon, M.; Tauc, M.; Namorado, M.C.; Martin, D.; Reyes, J.L.; Poujeol, P. Zinc protects renal function during cadmium intoxication in the rat. Am. J. Physiol. Ren. Physiol. 2006, 290, F127-F137. [CrossRef] [PubMed]
190. Zhang, D.; Liu, J.; Gao, J.; Shahzad, M.; Han, Z.; Wang, Z.; Li, J.; Sjolinder, H. Zinc supplementation protects against cadmium accumulation and cytotoxicity in Madin-Darby bovine kidney cells. PLoS ONE 2014, 9, e103427. [CrossRef] [PubMed]
191. Matovic, V.; Buha, A.; Bulat, Z.; Dukic-Cosic, D. Cadmium toxicity revisited: Focus on oxidative stress induction and interactions with zinc and magnesium. Arhiv Hig. Rada Toksikol. 2011, 62, 65-76. [CrossRef] [PubMed]
192. Matovic, V.; Plamenac Bulat, Z.; Djukic-Cosic, D.; Soldatovic, D. Antagonism between cadmium and magnesium: A possible role of magnesium in therapy of cadmium intoxication. Magnes. Res. 2010, 23, 19-26. [PubMed]
193. 2+depletion. Kidney Int. 1992, 41, 1237-1244. [CrossRef] [PubMed]
194. Djukic-Cosic, D.; Ninkovic, M.; Malicevic, Z.; Matovic, V.; Soldatovic, D. Effect of magnesium pretreatment on reduced glutathione levels in tissues of mice exposed to acute and subacute cadmium intoxication: A time course study. Magnes. Res. 2007, 20, 177-186. [PubMed]
195. Huang, M.; Choi, S.J.; Kim, D.W.; Kim, N.Y.; Bae, H.S.; Yu, S.D.; Kim, D.S.; Kim, H.; Choi, B.S.; Yu, I.J.; et al. Evaluation of factors associated with cadmium exposure and kidney function in the general population. Environ. Toxicol. 2011, 28, 563-570. [CrossRef] [PubMed]
196. Ferraro, P.M.; Costanzi, S.; Naticchia, A.; Sturniolo, A.; Gambaro, G. Low level exposure to cadmium increases the risk of chronic kidney disease: Analysis of the NHANES 1999-2006. BMC Public Health 2010, 10, 304. [CrossRef] [PubMed]
197. Navas-Acien, A.; Tellez-Plaza, M.; Guallar, E.; Muntner, P.; Silbergeld, E.; Jaar, B.; Weaver, V. Blood cadmium and lead and chronic kidney disease in US adults: A joint analysis. Am. J. Epidemiol. 2009, 170, 1156-1164. [CrossRef] [PubMed]
198. Hellstrom, L.; Elinder, C.G.; Dahlberg, B.; Lundberg, M.; Jarup, L.; Persson, B.; Axelson, O. Cadmium exposure and end-stage renal disease. Am. J. Kidney Dis. 2001, 38, 1001-1008. [CrossRef] [PubMed]
199. Chen, B.; Lamberts, L.V.; Behets, G.J.; Zhao, T.; Zhou, M.; Liu, G.; Hou, X.; Guan, G.; D’Haese, P.C. Selenium, lead, and cadmium levels in renal failure patients in China. Biol. Trace Elem. Res. 2009, 131, 1-12. [CrossRef] [PubMed]
200. Gonick, H.C. Nephrotoxicity of cadmium & lead. Ind. J. Med. Res. 2008, 128, 335-352.
201. Lauwerys, R.; Bernard, A.; Cardenas, A. Monitoring of early nephrotoxic effects of industrial chemicals. Toxicol. Lett. 1992, 64-65, 33-42. [CrossRef]
202. Ginsberg, G.L. Cadmium risk assessment in relation to background risk of chronic kidney disease. J. Toxicol. Environ. Health A 2012, 75, 374-390. [CrossRef] [PubMed]
203. Hwangbo, Y.; Weaver, V.M.; Tellez-Plaza, M.; Guallar, E.; Lee, B.K.; Navas-Acien, A. Blood cadmium and estimated glomerular filtration rate in Korean adults. Environ. Health Perspect. 2011, 119, 1800-1805. [CrossRef] [PubMed]
204. Porter, G.A. Risk factors for toxic nephropathies. Toxicol. Lett. 1989, 46, 269-279. [CrossRef]
205. Roels, H.A.; Hoet, P.; Lison, D. Usefulness of biomarkers of exposure to inorganic mercury, lead, or cadmium in controlling occupational and environmental risks of nephrotoxicity. Ren. Fail. 1999, 21, 251-262. [CrossRef] [PubMed]
206. Mueller, P.W.; Price, R.G.; Finn, W.F. New approaches for detecting thresholds of human nephrotoxicity using cadmium as an example. Environ. Health Perspect. 1998, 106, 227-230. [CrossRef] [PubMed]
207. Jayatilake, N.; Mendis, S.; Maheepala, P.; Mehta, F.R. Chronic kidney disease of uncertain aetiology:Prevalence and causative factors in a developing country. BMC Nephrol. 2013, 14, 180. [CrossRef] [PubMed]
208. Kim, N.H.; Hyun, Y.Y.; Lee, K.B.; Chang, Y.; Ryu, S.; Oh, K.H.; Ahn, C. Environmental heavy metal exposure and chronic kidney disease in the general population. J. Korean Med. Sci. 2015, 30, 272-277. [CrossRef] [PubMed]
209. Thomas, L.D.; Elinder, C.G.; Wolk, A.; Akesson, A. Dietary cadmium exposure and chronic kidney disease:A population-based prospective cohort study of men and women. Int. J. Hyg. Environ. Health 2014, 217, 720-725. [CrossRef] [PubMed]
210. Satarug, S.; Vesey, D.A.; Gobe, G.C. Kidney Cadmium Toxicity, Diabetes and High Blood Pressure: The Perfect Storm. Tohoku J. Exp. Med. 2017, 241, 65-87. [CrossRef] [PubMed]
211. Hayslett, J.P. Functional adaptation to reduction in renal mass. Physiol. Rev. 1979, 59, 137-164. [PubMed]
212. Zalups, R.K.; Fraser, J.; Koropatnick, J. Enhanced transcription of metallothionein genes in rat kidney:Effect of uninephrectomy and compensatory renal growth. Am. J. Physiol. 1995, 268, F643-F650. [PubMed]
213. Edwards, J.R.; Prozialeck, W.C. Cadmium, diabetes and chronic kidney disease. Toxicol. Appl. Pharmacol. 2009, 238, 289-293. [CrossRef] [PubMed]
214. Nordberg, G.F.; Jin, T.; Wu, X.; Lu, J.; Chen, L.; Lei, L.; Hong, F.; Nordberg, M. Prevalence of kidney dysfunction in humans-relationship to cadmium dose, metallothionein, immunological and metabolic factors. Biochimie 2009, 91, 1282-1285. [CrossRef] [PubMed]
215. Li, Y.; Zhang, Y.;Wang,W.;Wu, Y. Association of urinary cadmium with risk of diabetes: A meta-analysis. Environ. Sci. Pollut. Res. Int. 2017, 24, 10083-10090. [CrossRef] [PubMed]
216. Schrijvers, B.F.; De Vriese, A.S.; Flyvbjerg, A. From hyperglycemia to diabetic kidney disease: The role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr. Rev. 2004, 25, 971-1010. [CrossRef] [PubMed]
217. Bell, R.R.; Early, J.L.; Nonavinakere, V.K.; Mallory, Z. Effect of cadmium on blood glucose level in the rat. Toxicol. Lett. 1990, 54, 199-205. [CrossRef]
218. Chapatwala, K.D.; Boykin, M.; Butts, A.; Rajanna, B. Effect of intraperitoneally injected cadmium on renal and hepatic gluconeogenic enzymes in rats. Drug Chem. Toxicol. 1982, 5, 305-317. [CrossRef] [PubMed]
219. Lei, L.J.; Jin, T.Y.; Zhou, Y.F. Insulin expression in rats exposed to cadmium. Biomed. Environ. Sci. 2007, 20, 295-301. [PubMed]
220. Merali, Z.; Singhal, R.L. Diabetogenic effects of chronic oral cadmium adminstration to neonatal rats. Br. J. Pharmacol. 1980, 69, 151-157. [CrossRef] [PubMed]
221. Lei, L.J.; Jin, T.Y.; Zhou, Y.F. Effects of cadmium on levels of insulin in rats. J. Hyg. Res. 2005, 34, 394-396.
222. Jin, T.; Nordberg, G.; Sehlin, J.; Wallin, H.; Sandberg, S. The susceptibility to nephrotoxicity of streptozotocin-induced diabetic rats subchronically exposed to cadmium chloride in drinking water. Toxicology 1999, 142, 69-75. [CrossRef]
223. Bernard, A.; Schadeck, C.; Cardenas, A.; Buchet, J.P.; Lauwerys, R. Potentiation of diabetic glomerulopathy in uninephrectomized rats subchronically exposed to cadmium. Toxicol. Lett. 1991, 58, 51-57. [CrossRef]
224. Jin, T.; Nordberg, G.F.; Sehlin, J.; Leffler, P.; Wu, J. The susceptibility of spontaneously diabetic mice to cadmium-metallothionein nephrotoxicity. Toxicology 1994, 89, 81-90. [CrossRef]
225. Haswell-Elkins, M.; Satarug, S.; O’Rourke, P.; Moore, M.; Ng, J.; McGrath, V.;Walmby, M. Striking association between urinary cadmium level and albuminuria among Torres Strait Islander people with diabetes. Environ. Res. 2008, 106, 379-383. [CrossRef] [PubMed]
226. Buchet, J.P.; Lauwerys, R.; Roels, H.; Bernard, A.; Bruaux, P.; Claeys, F.; Ducoffre, G.; de Plaen, P.; Staessen, J.; Amery, A.; et al. Renal effects of cadmium body burden of the general population. Lancet 1990, 336, 699-702. [CrossRef]
227. Satarug, S.; Ujjin, P.; Vanavanitkun, Y.; Baker, J.R.; Moore, M.R. Influence of body iron store status and cigarette smoking on cadmium body burden of healthy Thai women and men. Toxicol. Lett. 2004, 148, 177-185. [CrossRef] [PubMed]
228. Berglund, M.; Akesson, A.; Nermell, B.; Vahter, M. Intestinal absorption of dietary cadmium in women depends on body iron stores and fiber intake. Environ. Health Perspect. 1994, 102, 1058-1066. [CrossRef] [PubMed]
229. Akesson, A.; Berglund, M.; Schutz, A.; Bjellerup, P.; Bremme, K.; Vahter, M. Cadmium exposure in pregnancy and lactation in relation to iron status. Am. J. Public Health 2002, 92, 284-287. [CrossRef] [PubMed]
230. Kim, D.W.; Kim, K.Y.; Choi, B.S.; Youn, P.; Ryu, D.Y.; Klaassen, C.D.; Park, J.D. Regulation of metal transporters by dietary iron, and the relationship between body iron levels and cadmium uptake. Arch. Toxicol. 2007, 81, 327-334. [CrossRef] [PubMed]
231. Vesey, D.A. Transport pathways for cadmium in the intestine and kidney proximal tubule: Focus on the interaction with essential metals. Toxicol. Lett. 2010, 198, 13-19. [CrossRef] [PubMed]
232. DeWitt, R.D. Pediatric lead exposure and the water crisis in Flint, Michigan. J. Am. Acad. Phys. Assist. 2017, 30, 43-46. [CrossRef] [PubMed]
233. Kennedy, C.; Yard, E.; Dignam, T.; Buchanan, S.; Condon, S.; Brown, M.J.; Raymond, J.; Rogers, H.S.; Sarisky, J.; de Castro, R.; et al. Blood Lead Levels Among Children Aged. MMWR 2016, 65, 650-654. [PubMed]
234. Shah, K.K.; Oleske, J.M.; Gomez, H.F.; Davidow, A.L.; Bogden, J.D. Blood Lead Concentrations of Children in the United States: A Comparison of States Using Two Very Large Databases. J. Pediatr. 2017. [CrossRef] [PubMed]
235. Centers of Disease Control and Prevention (CDC). Very high blood lead levels among adults-United States, 2002-2011. MMWR 2013, 62, 967-971.
236. Raymond, J.; Brown, M.J. Childhood Blood Lead Levels in Children Aged. MMWR 2017, 66, 1-10. [PubMed]
237. Alarcon,W.A. Elevated Blood Lead Levels Among Employed Adults-United States, 1994-2013. MMWR 2016, 63, 59-65. [CrossRef] [PubMed]
238. Goyer, R.A. Lead toxicity: Current concerns. Environ. Health Perspect. 1993, 100, 177-187. [CrossRef] [PubMed]
239. Dapul, H.; Laraque, D. Lead poisoning in children. Adv. Pediatr. 2014, 61, 313-333. [CrossRef] [PubMed]
240. Fowler, B.A. Mechanisms of Kidney Cell Injury from Metals. Environ. Health Perspect. 1992, 100, 57-63. [CrossRef]
241. Smith, D.R.; Kahng, M.W.; Quintanilla-Vega, B.; Fowler, B.A. High-affinity renal lead-binding proteins in environmentally-exposed humans. Chem. Biol. Interact. 1998, 115, 39-52. [CrossRef]
242. Oskarsson, A.; Squibb, K.S.; Fowler, B.A. Intracellular binding of lead in the kidney: The partial isolation and characterization of postmitochondrial lead binding components. Biochem. Biophys. Res. Commun. 1982, 104, 290-298. [CrossRef]
243. DuVal, G.; Fowler, B.A. Preliminary purification and characterization studies of a low molecular weight, high affinity cytosolic lead-binding protein in rat brain. Biochem. Biophys. Res. Commun. 1989, 159, 177-184. [CrossRef]
244. Fowler, B.A.; DuVal, G. Effects of lead on the kidney: Roles of high-affinity lead-binding proteins. Environ. Health Perspect. 1991, 91, 77-80. [CrossRef] [PubMed]
245. Swenberg, J.A.; Short, B.; Borghoff, S.; Strasser, J.; Charbonneau, M. The comparative pathobiology of alpha 2u-globulin nephropathy. Toxicol. Appl. Pharmacol. 1989, 97, 35-46. [CrossRef]
246. Goyer, R.A. Mechanisms of lead and cadmium nephrotoxicity. Toxicol. Lett. 1989, 46, 153-162. [CrossRef]
247. Marchetti, C. Role of calcium channels in heavy metal toxicity. ISRN Toxicol. 2013, 2013, 184360. [CrossRef] [PubMed]
248. Goyer, R.A. Toxic and essential metal interactions. Annu. Rev. Nutr. 1997, 17, 37-50. [CrossRef] [PubMed]
249. Ziegler, E.E.; Edwards, B.B.; Jensen, R.L.; Mahaffey, K.R.; Fomon, S.J. Absorption and retention of lead by infants. Pediatr. Res. 1978, 12, 29-34. [CrossRef] [PubMed]
250. Chen, J.; Li, M.; Lv, Q.; Chen, G.; Li, Y.; Li, S.; Mo, Y.; Ou, S.; Yuan, Z.; Huang, M.; et al. Blood lead level and its relationship to essential elements in preschool children from Nanning, China. J. Trace Elem. Med. Biol. 2015, 30, 137-141. [CrossRef] [PubMed]
251. Six, K.M.; Goyer, R.A. Experimental enhancement of lead toxicity by low dietary calcium. J. Lab. Clin. Med. 1970, 76, 933-942. [PubMed]
252. Bogden, J.D.; Gertner, S.B.; Christakos, S.; Kemp, F.W.; Yang, Z.; Katz, S.R.; Chu, C. Dietary calcium modifies concentrations of lead and other metals and renal calbindin in rats. J. Nutr. 1992, 122, 1351-1360. [PubMed]
253. Mahaffey, K.R.; Gartside, P.S.; Glueck, C.J. Blood lead levels and dietary calcium intake in 1- to 11-year-old children: The Second National Health and Nutrition Examination Survey, 1976 to 1980. Pediatrics 1986, 78, 257-262. [PubMed]
254. Blake, K.C.; Mann, M. Effect of calcium and phosphorus on the gastrointestinal absorption of 203Pb in man. Environ. Res. 1983, 30, 188-194. [CrossRef]
255. Barton, J.C. Active transport of lead-210 by everted segments of rat duodenum. Am. J. Physiol. 1984, 247, G193-G198. [PubMed]
256. Giebisch, G.; Windhager, E. Transport of urea, glucose, phosphate, calcium, magnesium, and organic solutes. In Medical Physiology, 2nd ed.; Boron, W.F., Boulpaep, E.L., Eds.; Elsevier: Philadelphia, PA, USA, 2012; pp. 797-820.
257. Kerper, L.E.; Hinkle, P.M. Cellular uptake of lead is activated by depletion of intracellular calcium stores. J. Biol. Chem. 1997, 272, 8346-8352. [CrossRef] [PubMed]
258. Simons, T.J. Lead transport and binding by human erythrocytes in vitro. Pflugers Arch. 1993, 423, 307-313. [CrossRef] [PubMed]
259. Simons, T.J. Lead-calcium interactions in cellular lead toxicity. Neurotoxicology 1993, 14, 77-85. [PubMed]
260. Simons, T.J.; Pocock, G. Lead enters bovine adrenal medullary cells through calcium channels. J. Neurochem. 1987, 48, 383-389. [CrossRef] [PubMed]
261. 2+channels transiently expressed in human embryonic kidney 293 cells. Mol. Pharmacol. 2002, 62, 1418-1430. [CrossRef] [PubMed]
262. Chiu, T.Y.; Teng, H.C.; Huang, P.C.; Kao, F.J.; Yang, D.M. Dominant role of Orai1 with STIM1 on the cytosolic entry and cytotoxicity of lead ions. Toxicol. Sci. 2009, 110, 353-362. [CrossRef] [PubMed]
263. Pfleger, H.; Wolf, H.U. Activation of membrane-bound high-affinity calcium ion-sensitive adenosine triphosphatase of human erythrocytes by bivalent metal ions. Biochem. J. 1975, 147, 359-361. [CrossRef] [PubMed]
264. Alexander, J.; Aaseth, J.;Mikalsen, A. Excretion of lead in rat bile-The role of glutathione. Acta Pharmacol. Toxicol. 1986, 59 (Suppl. S7), 486-489. [CrossRef]
265. Patrick, L. Lead toxicity part II: The role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity. Altern. Med. Rev. 2006, 11, 114-127. [PubMed]
266. Basgen, J.M.; Sobin, C. Early chronic low-level lead exposure produces glomerular hypertrophy in young C57BL/6J mice. Toxicol. Lett. 2014, 225, 48-56. [CrossRef] [PubMed]
267. Ritz, E.; Mann, J.; Stoeppler, M. Lead and the kidney. Adv. Nephrol. Necker Hosp. 1988, 17, 241-274. [PubMed]
268. Navarro-Moreno, L.G.; Quintanar-Escorza, M.A.; Gonzalez, S.; Mondragon, R.; Cerbon-Solorzano, J.; Valdes, J.; Calderon-Salinas, J.V. Effects of lead intoxication on intercellular junctions and biochemical alterations of the renal proximal tubule cells. Toxicol. In Vitro 2009, 23, 1298-1304. [CrossRef] [PubMed]
269. Cardenas, A.; Roels, H.; Bernard, A.M.; Barbon, R.; Buchet, J.P.; Lauwerys, R.R.; Rosello, J.; Ramis, I.; Mutti, A.; Franchini, I.; et al. Markers of early renal changes induced by industrial pollutants. II. Application to workers exposed to lead. Br. J. Ind. Med. 1993, 50, 28-36. [CrossRef] [PubMed]
270. Soliman, M.M.; Baiomy, A.A.; Yassin, M.H. Molecular and Histopathological Study on the Ameliorative Effects of Curcumin Against Lead Acetate-Induced Hepatotoxicity and Nephrototoxicity in Wistar Rats. Biol. Trace Elem. Res. 2015, 167, 91-102. [CrossRef] [PubMed]
271. Zhou, R.; Xu, Y.; Shen, J.; Han, L.; Chen, X.; Feng, X.; Kuang, X. Urinary KIM-1: A novel biomarker for evaluation of occupational exposure to lead. Sci. Rep. 2016, 6, 38930. [CrossRef] [PubMed]
272. Garcon, G.; Leleu, B.; Marez, T.; Zerimech, F.; Haguenoer, J.M.; Furon, D.; Shirali, P. Biomonitoring of the adverse effects induced by the chronic exposure to lead and cadmium on kidney function: Usefulness of alpha-glutathione S-transferase. Sci. Total Environ. 2007, 377, 165-172. [CrossRef] [PubMed]
273. Zhang, Z.; Gao, X.; Guo, M.; Jiang, H.; Cao, Y.; Zhang, N. The Protective Effect of Baicalin Against Lead-Induced Renal Oxidative Damage in Mice. Biol. Trace Elem. Res. 2017, 175, 129-135. [CrossRef] [PubMed]
274. Wang, L.; Wang, H.; Hu, M.; Cao, J.; Chen, D.; Liu, Z. Oxidative stress and apoptotic changes in primary cultures of rat proximal tubular cells exposed to lead. Arch. Toxicol. 2009, 83, 417-427. [CrossRef] [PubMed]
275. Dewanjee, S.; Sahu, R.; Karmakar, S.; Gangopadhyay, M. Toxic effects of lead exposure in Wistar rats: Involvement of oxidative stress and the beneficial role of edible jute (Corchorus olitorius) leaves. Food Chem. Toxicol. 2013, 55, 78-91. [CrossRef] [PubMed]
276. Liu, G.; Wang, Z.K.; Wang, Z.Y.; Yang, D.B.; Liu, Z.P.; Wang, L. Mitochondrial permeability transition and its regulatory components are implicated in apoptosis of primary cultures of rat proximal tubular cells exposed to lead. Arch. Toxicol. 2016, 90, 1193-1209. [CrossRef] [PubMed]
277. Bonora, M.; Morganti, C.; Morciano, G.; Giorgi, C.;Wieckowski, M.R.; Pinton, P. Comprehensive analysis of mitochondrial permeability transition pore activity in living cells using fluorescence-imaging-based techniques. Nat. Protoc. 2016, 11, 1067-1080. [CrossRef] [PubMed]
278. Wang, L.; Cao, J.; Chen, D.; Liu, X.; Lu, H.; Liu, Z. Role of oxidative stress, apoptosis, and intracellular homeostasis in primary cultures of rat proximal tubular cells exposed to cadmium. Biol. Trace Elem. Res. 2009, 127, 53-68. [CrossRef] [PubMed]
279. Jacotot, E.; Deniaud, A.; Borgne-Sanchez, A.; Touat, Z.; Briand, J.P.; Le Bras, M.; Brenner, C. Therapeutic peptides: Targeting the mitochondrion to modulate apoptosis. Biochim. Biophys. Acta 2006, 1757, 1312-1323. [CrossRef] [PubMed]
280. Goldstein, G.W.; Ar, D. Lead activates calmodulin sensitive processes. Life Sci. 1983, 33, 1001-1006. [CrossRef]
281. 2+in calmodulin. Arch. Toxicol. 1983, 54, 61-70. [CrossRef] [PubMed]
282. Stoclet, J.C.; Gerard, D.; Kilhoffer, M.C.; Lugnier, C.; Miller, R.; Schaeffer, P. Calmodulin and its role in intracellular calcium regulation. Prog. Neurobiol. 1987, 29, 321-364. [CrossRef]
283. Wang, H.; Wang, Z.K.; Jiao, P.; Zhou, X.P.; Yang, D.B.; Wang, Z.Y.; Wang, L. Redistribution of subcellular calcium and its effect on apoptosis in primary cultures of rat proximal tubular cells exposed to lead. Toxicology 2015, 333, 137-146. [CrossRef] [PubMed]
284. Zhang, J.; Cao, H.; Zhang, Y.; Ma, J.; Wang, J.; Gao, Y.; Zhang, X.; Zhang, F.; Chu, L. Nephroprotective effect of calcium channel blockers against toxicity of lead exposure in mice. Toxicol. Lett. 2013, 218, 273-280. [CrossRef] [PubMed]
285. Staessen, J.; Yeoman, W.B.; Fletcher, A.E.; Markowe, H.L.; Marmot, M.G.; Rose, G.; Semmence, A.; Shipley, M.J.; Bulpitt, C.J. Blood lead concentration, renal function, and blood pressure in London civil servants. Br. J. Ind. Med. 1990, 47, 442-447. [CrossRef] [PubMed]
286. Ekong, E.B.; Jaar, B.G.; Weaver, V.M. Lead-related nephrotoxicity: A review of the epidemiologic evidence. Kidney Int. 2006, 70, 2074-2084. [CrossRef] [PubMed]
287. Fadrowski, J.J.; Navas-Acien, A.; Tellez-Plaza, M.; Guallar, E.; Weaver, V.M.; Furth, S.L. Blood lead level and kidney function in US adolescents: The Third National Health and Nutrition Examination Survey. Arch. Int. Med. 2010, 170, 75-82. [CrossRef] [PubMed]
288. Spector, J.T.; Navas-Acien, A.; Fadrowski, J.; Guallar, E.; Jaar, B.; Weaver, V.M. Associations of blood lead with estimated glomerular filtration rate using MDRD, CKD-EPI and serum cystatin C-based equations. Nephrol. Dial. Transplant. 2011, 26, 2786-2792. [CrossRef] [PubMed]
289. Landrigan, P.J. Current issues in the epidemiology and toxicology of occupational exposure to lead. Environ. Health Perspect. 1990, 89, 61-66. [CrossRef] [PubMed]
290. Hernandez-Serrato, M.I.; Fortoul, T.I.; Rojas-Martinez, R.; Mendoza-Alvarado, L.R.; Canales-Trevino, L.; Bochichio-Riccardelli, T.; Avila-Costa, M.R.; Olaiz-Fernandez, G. Lead blood concentrations and renal function evaluation: Study in an exposed Mexican population. Environ. Res. 2006, 100, 227-231. [CrossRef] [PubMed]
291. Chung, S.; Chung, J.H.; Kim, S.J.; Koh, E.S.; Yoon, H.E.; Park, C.W.; Chang, Y.S.; Shin, S.J. Blood lead and cadmium levels and renal function in Korean adults. Clin. Exp. Nephrol. 2014, 18, 726-734. [CrossRef] [PubMed]
292. Sommar, J.N.; Svensson, M.K.; Bjor, B.M.; Elmstahl, S.I.; Hallmans, G.; Lundh, T.; Schon, S.M.; Skerfving, S.; Bergdahl, I.A. End-stage renal disease and low level exposure to lead, cadmium and mercury; a population-based, prospective nested case-referent study in Sweden. Environ. Health 2013, 12, 9. [CrossRef] [PubMed]
293. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Mercury. In ATSDR’s Toxicological Profiles; U.S. Department of Health and Human Services, Public Health Service (PHS); Centers for Disease Control and Prevention: Atlanta, GA, USA, 2008.
294. Clarkson, T.W.; Magos, L. The toxicology of mercury and its chemical compounds. Crit. Rev. Toxicol. 2006, 36, 609-662. [CrossRef] [PubMed]
295. Rooney, J.P. The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. Toxicology 2007, 234, 145-156. [CrossRef] [PubMed]
296. Zalups, R.K. Molecular interactions with mercury in the kidney. Pharmacol. Rev. 2000, 52, 113-143. [PubMed]
297. Risher, J.F.; De Rosa, C.T. Inorganic: The other mercury. J. Environ. Health 2007, 70, 9-16. [PubMed]
298. Gage, J.C. Distribution and Excretion of Methyl and Phenyl Mercury Salts. Br. J. Ind. Med. 1964, 21, 197-202. [CrossRef] [PubMed]
299. Norseth, T.; Clarkson, T.W. Studies on the biotransformation of 203Hg-labeled methyl mercury chloride in rats. Arch. Environ. Health 1970, 21, 717-727. [CrossRef] [PubMed]
300. Norseth, T.; Clarkson, T.W. Biotransformation of methylmercury salts in the rat studied by specific determination of inorganic mercury. Biochem. Pharmacol. 1970, 19, 2775-2783. [CrossRef]
301. Omata, S.; Sato, M.; Sakimura, K.; Sugano, H. Time-dependent accumulation of inorganic mercury in subcellular fractions of kidney, liver, and brain of rats exposed to methylmercury. Arch. Toxicol. 1980, 44, 231-241. [CrossRef] [PubMed]
302. Nielsen, J.B. Toxicokinetics of mercuric chloride and methylmercuric chloride in mice. J. Toxicol. Environ. Health 1992, 37, 85-122. [CrossRef] [PubMed]
303. Zalups, R.K. Early aspects of the intrarenal distribution of mercury after the intravenous administration of mercuric chloride. Toxicology 1993, 79, 215-228. [CrossRef]
304. Murphy, M.J.; Culliford, E.J.; Parsons, V. A case of poisoning with mercuric chloride. Resuscitation 1979, 7, 35-44. [CrossRef]
305. Rowens, B.; Guerrero-Betancourt, D.; Gottlieb, C.A.; Boyes, R.J.; Eichenhorn, M.S. Respiratory failure and death following acute inhalation of mercury vapor. A clinical and histologic perspective. Chest 1991, 99, 185-190. [CrossRef] [PubMed]
306. Samuels, E.R.; Heick, H.M.; McLaine, P.N.; Farant, J.P. A case of accidental inorganic mercury poisoning. J. Anal. Toxicol. 1982, 6, 120-122. [CrossRef] [PubMed]
307. Yasutake, A.; Hirayama, K.; Inoue, M. Mechanism of urinary excretion of methylmercury in mice. Arch. Toxicol. 1989, 63, 479-483. [CrossRef] [PubMed]
308. Hughes, W.L. A physicochemical rationale for the biological activity of mercury and its compounds. Ann. N. Y. Acad. Sci. 1957, 65, 454-460. [CrossRef] [PubMed]
309. Fuhr, B.J.; Rabenstein, D.L. Nuclear magnetic resonance studies of the solution chemistry of metal complexes. IX. The binding of cadmium, zinc, lead, and mercury by glutathione. J. Am. Chem. Soc. 1973, 95, 6944-6950. [CrossRef] [PubMed]
310. Rubino, F.M.; Verduci, C.; Giampiccolo, R.; Pulvirenti, S.; Brambilla, G.; Colombi, A. Molecular characterization of homo- and heterodimeric mercury(II)-bis-thiolates of some biologically relevant thiols by electrospray ionization and triple quadrupole tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 2004, 15, 288-300. [CrossRef] [PubMed]
311. 2+in the renal proximal tubule. J. Am. Soc. Nephrol. 2000, 11, 394-402. [PubMed]
312. Cannon, V.T.; Zalups, R.K.; Barfuss, D.W. Amino acid transporters involved in luminal transport of mercuric conjugates of cysteine in rabbit proximal tubule. J. Pharmacol. Exp. Ther. 2001, 298, 780-789. [PubMed]
313. Zalups, R.K. Basolateral uptake of inorganic mercury in the kidney. Toxicol. Appl. Pharmacol. 1998, 151, 192-199. [CrossRef] [PubMed]
314. Zalups, R.K.; Lash, L.H. Binding of mercury in renal brush-border and basolateral membrane-vesicles. Biochem. Pharmacol. 1997, 53, 1889-1900. [CrossRef]
315. Zalups, R.K.; Minor, K.H. Luminal and basolateral mechanisms involved in the renal tubular uptake of inorganic mercury. J. Toxicol. Environ. Health 1995, 46, 73-100. [CrossRef] [PubMed]
316. Zalups, R.K.; Barfuss, D.W. Accumulation and handling of inorganic mercury in the kidney after coadministration with glutathione. J. Toxicol. Environ. Health 1995, 44, 385-399. [CrossRef] [PubMed]
317. Zalups, R.K.; Barfuss, D.W. Nephrotoxicity of inorganic mercury co-administrated with L-cysteine. Toxicology 1996, 109, 15-29. [CrossRef]
318. Zalups, R.K.; Barfuss, D.W. Participation of mercuric conjugates of cysteine, homocysteine, and N-acetylcysteine in mechanisms involved in the renal tubular uptake of inorganic mercury. J. Am. Soc. Nephrol. 1998, 9, 551-561. [PubMed]
319. Bridges, C.C.; Bauch, C.; Verrey, F.; Zalups, R.K. Mercuric conjugates of cysteine are transported by the amino acid transporter system b(0,+): Implications of molecular mimicry. J. Am. Soc. Nephrol. 2004, 15, 663-673. [CrossRef] [PubMed]
320. 0,+and the renal epithelial transport and toxicity of inorganic mercury. Am. J. Pathol. 2004, 165, 1385-1394. [CrossRef]
321. 0,+and the transport of thiol-S-conjugates of methylmercury. J. Pharmacol. Exp. Ther. 2006, 319, 948-956. [CrossRef] [PubMed]
322. Zalups, R.K.; Barfuss, D.W. Pretreatment with p-aminohippurate inhibits the renal uptake and accumulation of injected inorganic mercury in the rat. Toxicology 1995, 103, 23-35. [CrossRef]
323. Zalups, R.K.; Barfuss, D.W. Small aliphatic dicarboxylic acids inhibit renal uptake of administered mercury. Toxicol. Appl. Pharmacol. 1998, 148, 183-193. [CrossRef] [PubMed]
324. Zalups, R.K. Organic anion transport and action of gamma-glutamyl transpeptidase in kidney linked mechanistically to renal tubular uptake of inorganic mercury. Toxicol. Appl. Pharmacol. 1995, 132, 289-298. [CrossRef] [PubMed]
325. Zalups, R.K. Basolateral uptake of mercuric conjugates of N-acetylcysteine and cysteine in the kidney involves the organic anion transport system. J. Toxicol. Environ. Health A 1998, 55, 13-29. [CrossRef] [PubMed]
326. Ferrier, B.; Martin, M.; Roch-Ramel, F. Effects of p-aminohippurate and pyrazinoate on the renal excretion of salicylate in the rat: A micropuncture study. J. Pharmacol. Exp. Ther. 1983, 224, 451-458. [PubMed]
327. Koh, A.S.; Simmons-Willis, T.A.; Pritchard, J.B.; Grassl, S.M.; Ballatori, N. Identification of a mechanism by which the methylmercury antidotes N-acetylcysteine and dimercaptopropanesulfonate enhance urinary metal excretion: Transport by the renal organic anion transporter-1. Mol. Pharmacol. 2002, 62, 921-926. [CrossRef] [PubMed]
328. Kojima, R.; Sekine, T.; Kawachi, M.; Cha, S.H.; Suzuki, Y.; Endou, H. Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. J. Am. Soc. Nephrol. 2002, 13, 848-857. [PubMed]
329. Motohashi, H.; Sakurai, Y.; Saito, H.; Masuda, S.; Urakami, Y.; Goto, M.; Fukatsu, A.; Ogawa, O.; Inui, K. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J. Am. Soc. Nephrol. 2002, 13, 866-874. [PubMed]
330. Pritchard, J.B. Coupled transport of p-aminohippurate by rat kidney basolateral membrane vesicles. Am. J. Physiol. 1988, 255, F597-F604. [PubMed]
331. Shimomura, A.; Chonko, A.M.; Grantham, J.J. Basis for heterogeneity of para-aminohippurate secretion in rabbit proximal tubules. Am. J. Physiol. 1981, 240, F430-F436. [PubMed]
332. Tanaka, T.; Naganuma, A.; Miura, N.; Imura, N. Role of testosterone in gamma-glutamyltranspeptidasedependent renal methylmercury uptake in mice. Toxicol. Appl. Pharmacol. 1992, 112, 58-63. [CrossRef]
333. Ullrich, K.J.; Rumrich, G.; Fritzsch, G.; Kloss, S. Contraluminal para-aminohippurate (PAH) transport in the proximal tubule of the rat kidney. II. Specificity: Aliphatic dicarboxylic acids. Pflugers Arch. 1987, 408, 38-45. [CrossRef] [PubMed]
334. Zalups, R.K.; Ahmad, S. Handling of cysteine S-conjugates of methylmercury in MDCK cells expressing human OAT1. Kidney Int. 2005, 68, 1684-1699. [CrossRef] [PubMed]
335. Zalups, R.K.; Ahmad, S. Handling of the homocysteine S-conjugate of methylmercury by renal epithelial cells: Role of organic anion transporter 1 and amino acid transporters. J. Pharmacol. Exp. Ther. 2005, 315, 896-904. [CrossRef] [PubMed]
336. Zalups, R.K.; Ahmad, S. Transport of N-acetylcysteine S-conjugates of methylmercury in Madin-Darby canine kidney cells stably transfected with human isoform of organic anion transporter 1. J. Pharmacol. Exp. Ther. 2005, 314, 1158-1168. [CrossRef] [PubMed]
337. Aslamkhan, A.G.; Han, Y.H.; Yang, X.P.; Zalups, R.K.; Pritchard, J.B. Human renal organic anion transporter 1-dependent uptake and toxicity of mercuric-thiol conjugates in Madin-Darby canine kidney cells. Mol. Pharmacol. 2003, 63, 590-596. [CrossRef] [PubMed]
338. Zalups, R.K.; Ahmad, S. Homocysteine and the renal epithelial transport and toxicity of inorganic mercury:Role of basolateral transporter organic anion transporter 1. J. Am. Soc. Nephrol. 2004, 15, 2023-2031. [CrossRef] [PubMed]
339. Zalups, R.K.; Aslamkhan, A.G.; Ahmad, S. Human organic anion transporter 1 mediates cellular uptake of cysteine-S conjugates of inorganic mercury. Kidney Int. 2004, 66, 251-261. [CrossRef] [PubMed]
340. Cherian, M.G.; Clarkson, T.W. Biochemical changes in rat kidney on exposure to elemental mercury vapor:Effect on biosynthesis of metallothionein. Chem. Biol. Interact. 1976, 12, 109-120. [CrossRef]
341. Zalups, R.K.; Koropatnick, J. Temporal changes in metallothionein gene transcription in rat kidney and liver:Relationship to content of mercury and metallothionein protein. J. Pharmacol. Exp. Ther. 2000, 295, 74-82. [PubMed]
342. Ruprecht, J. Scientific Monograph for Dimaval; Heyltex Corporation: Houston, TX, USA, 2008.
343. Aposhian, H.V. DMSA and DMPS-Water soluble antidotes for heavy metal poisoning. Annu. Rev. Pharmacol. Toxicol. 1983, 23, 193-215. [CrossRef] [PubMed]
344. Aposhian, H.V.; Maiorino, R.M.; Gonzalez-Ramirez, D.; Zuniga-Charles, M.; Xu, Z.; Hurlbut, K.M.; Junco-Munoz, P.; Dart, R.C.; Aposhian, M.M. Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicology 1995, 97, 23-38. [CrossRef]
345. Aposhian, H.V.; Maiorino, R.M.; Rivera, M.; Bruce, D.C.; Dart, R.C.; Hurlbut, K.M.; Levine, D.J.; Zheng, W.; Fernando, Q.; Carter, D.; et al. Human studies with the chelating agents, DMPS and DMSA. J. Toxicol. Clin. Toxicol. 1992, 30, 505-528. [CrossRef] [PubMed]
346. Planas-Bohne, F. The effect of 2,3-dimercaptorpropane-1-sulfonate and dimercaptosuccinic acid on the distribution and excretion of mercuric chloride in rats. Toxicology 1981, 19, 275-278. [CrossRef]
347. Zalups, R.K. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury. J. Pharmacol. Exp. Ther. 1993, 267, 791-800. [PubMed]
348. Zalups, R.K.; Bridges, C.C. Relationships between the renal handling of DMPS and DMSA and the renal handling of mercury. Chem. Res. Toxicol. 2012, 25, 1825-1838. [CrossRef] [PubMed]
349. Rodiger, M.; Zhang, X.; Ugele, B.; Gersdorff, N.; Wright, S.H.; Burckhardt, G.; Bahn, A. Organic anion transporter 3 (OAT3) and renal transport of the metal chelator 2,3-dimercapto-1-propanesulfonic acid (DMPS). Can. J. Physiol. Pharmacol. 2010, 88, 141-146. [CrossRef] [PubMed]
350. Bahn, A.; Knabe, M.; Hagos, Y.; Rodiger, M.; Godehardt, S.; Graber-Neufeld, D.S.; Evans, K.K.; Burckhardt, G.; Wright, S.H. Interaction of the metal chelator 2,3-dimercapto-1-propanesulfonate with the rabbit multispecific organic anion transporter 1 (rbOAT1). Mol. Pharmacol. 2002, 62, 1128-1136. [CrossRef] [PubMed]
351. Burckhardt, B.C.; Drinkuth, B.; Menzel, C.; Konig, A.; Steffgen, J.; Wright, S.H.; Burckhardt, G. The renal Na(+)-dependent dicarboxylate transporter, NaDC-3, translocates dimethyl- and disulfhydryl-compounds and contributes to renal heavy metal detoxification. J. Am. Soc. Nephrol. 2002, 13, 2628-2638. [CrossRef] [PubMed]
352. Islinger, F.; Gekle, M.; Wright, S.H. Interaction of 2,3-dimercapto-1-propane sulfonate with the human organic anion transporter hOAT1. J. Pharmacol. Exp. Ther. 2001, 299, 741-747. [PubMed]
353. Bridges, C.C.; Joshee, L.; Zalups, R.K. MRP2 and the DMPS- and DMSA-mediated elimination of mercury in TR(-) and control rats exposed to thiol S-conjugates of inorganic mercury. Toxicol. Sci. 2008, 105, 211-220. [CrossRef] [PubMed]
354. Bridges, C.C.; Joshee, L.; Zalups, R.K. Multidrug resistance proteins and the renal elimination of inorganic mercury mediated by 2,3-dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid. J. Pharmacol. Exp. Ther. 2008, 324, 383-390. [CrossRef] [PubMed]
355. Bridges, C.C.; Joshee, L.; Zalups, R.K. Effect of DMPS and DMSA on the Placental and Fetal Disposition of Methylmercury. Placenta 2009, 30, 800-805. [CrossRef] [PubMed]
356. Bridges, C.C.; Zalups, R.K.; Joshee, L. Toxicological significance of renal Bcrp: Another potential transporter in the elimination of mercuric ions from proximal tubular cells. Toxicol. Appl. Pharmacol. 2015, 285, 110-117. [CrossRef] [PubMed]
357. Aremu, D.A.; Madejczyk, M.S.; Ballatori, N. N-acetylcysteine as a potential antidote and biomonitoring agent of methylmercury exposure. Environ. Health Perspect. 2008, 116, 26-31. [CrossRef] [PubMed]
358. Madejczyk, M.S.; Aremu, D.A.; Simmons-Willis, T.A.; Clarkson, T.W.; Ballatori, N. Accelerated urinary excretion of methylmercury following administration of its antidote N-acetylcysteine requires Mrp2/Abcc2, the apical multidrug resistance-associated protein. J. Pharmacol. Exp. Ther. 2007, 322, 378-384. [CrossRef] [PubMed]
359. McDowell, E.M.; Nagle, R.B.; Zalme, R.C.; McNeil, J.S.; Flamenbaum, W.; Trump, B.F. Studies on the pathophysiology of acute renal failure. I. Correlation of ultrastructure and function in the proximal tubule of the rat following administration of mercuric chloride. Virchows Arch. B Cell Pathol. 1976, 22, 173-196. [PubMed]
360. Zalme, R.C.; McDowell, E.M.; Nagle, R.B.; McNeil, J.S.; Flamenbaum, W.; Trump, B.F. Studies on the pathophysiology of acute renal failure. II. A histochemical study of the proximal tubule of the rat following administration of mercuric chloride. Virchows Arch. B Cell Pathol. 1976, 22, 197-216. [PubMed]
361. Rodin, A.E.; Crowson, C.N. Mercury nephrotoxicity in the rat. 2. Investigation of the intracellular site of mercury nephrotoxicity by correlated serial time histologic and histoenzymatic studies. Am. J. Pathol. 1962, 41, 485-499. [PubMed]
362. Gritzka, T.L.; Trump, B.F. Renal tubular lesions caused by mercuric chloride. Electron microscopic observations: Degeneration of the pars recta. Am. J. Pathol. 1968, 52, 1225-1277. [PubMed]
363. Zalups, R.K. Evidence for basolateral uptake of cadmium in the kidneys of rats. Toxicol. Appl. Pharmacol. 2000, 164, 15-23. [CrossRef] [PubMed]
364. Gotelli, C.A.; Astolfi, E.; Cox, C.; Cernichiari, E.; Clarkson, T.W. Early biochemical effects of an organic mercury fungicide on infants: “dose makes the poison”. Science 1985, 227, 638-640. [CrossRef] [PubMed]